Number of the records: 1
skúšanie klinické, fáza III, ako téma
SYS d017326 LBL 00000cx--j2200000---45-- 005 20250201155252.8 100 $a 19920513asloy0103----ba0 152 $b mesh 250 $a skúšanie klinické, fáza III, ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x PX $x SN $x ST $x VE $8 slo 300 1-
$a 2008(1993) $8 eng 300 1-
$a Clinical Trials (1980-1992) $8 eng 330 1-
$a Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries. $8 eng 450 $a pokusy klinické, tretia fáza, ako téma $5 e $8 slo 450 $a testy klinické, tretia fáza, ako téma $5 e $8 slo 450 $a štúdie klinické, fáza III, ako téma $5 e $8 slo 550 $3 sllk_un_auth*d015337 $Y Multicenter Studies as Topic $5 B $a štúdie multicentrické ako téma 675 $a 615.036 $v UDC-MRF-SK3 $z slo 686 $a E05.318.372.250.250.220 686 $a N05.715.360.330.250.250.220 686 $a N06.850.520.450.250.250.220 750 $a Clinical Trials, Phase III as Topic $8 eng 801 -0
$a US $b DNLM $c 19920513 801 -2
$a SK $b BA006 $c 19990922 801 -2
$a SK $b BA006 $c 20080702 801 -2
$a SK $b BA006 $c 20160216 820 $a for general design, methodology, economics, etc. of phase III clinical trials; a different heading CLINICAL TRIAL, PHASE III is used for reports of a specific phase III clinical trial $8 eng 980 $x M
Number of the records: 1